COVID-19, chronic inflammatory respiratory diseases and eosinophils-Observations from reported clinical case series

Allergy. 2020 Jul;75(7):1819-1822. doi: 10.1111/all.14353.
No abstract available

Keywords: asthma; biomarkers; eosinophils; inflammation; virus.

Publication types

  • Letter

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Betacoronavirus / metabolism*
  • CD4 Lymphocyte Count
  • COVID-19
  • Comorbidity
  • Coronavirus Infections / blood
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / virology
  • Cytokines / blood
  • Diabetes Mellitus / epidemiology*
  • Diabetes Mellitus / metabolism
  • Eosinophils / immunology*
  • Humans
  • Hypertension / drug therapy
  • Hypertension / epidemiology*
  • Hypertension / metabolism
  • Incidence
  • Lymphopenia
  • Pandemics
  • Peptidyl-Dipeptidase A / metabolism
  • Pneumonia, Viral / blood
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / virology
  • Risk Factors
  • SARS-CoV-2

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Cytokines
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2